Sort
15,842 grants matching “pancreatic cancer”
Combination Therapy: Targeting Pancreatic Cancer with a ROS Inducer and Gemcitabine
$192,268Katie Reindl · North Dakota State University · P20 · FY2018 · GM
Unraveling the functional contribution of extracellular vesicles in pancreatic cancer
$192,240Kathleen McAndrews · University Of Tx Md Anderson Can Ctr · K22 · FY2025 · CA
Development of Monoclonal Antibodies to Inhibit RAGE Activation in Pancreatic Cancer tumors
$192,133Estelle Leclerc · North Dakota State University · P20 · FY2018 · GM
SEROLOGICAL MARKERS OF PERIODONTAL DISEASE AND PANCREATIC CANCER RISK
$192,122Dominique S Michaud · Brown University · R21 · FY2011 · CA
Enhancing Enrollment for NOD and DETECT studies of the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer
$192,088Walter Gwang-Up Park · Stanford University · U01 · FY2019 · DK
Effects of salinomycin and binding target proteins in pancreatic cancer
$192,080Erxi Wu · North Dakota State University · P20 · FY2018 · GM
Quantitative Spectroscopic Imaging of Cancer Metabolites in Live Cells and Intact
$192,067Ji-Xin Cheng · Purdue University · R21 · FY2013 · CA
Adult pancreatic progenitor cells as target of early oncogenic events
$191,880Catherine Carriere · Dartmouth College · R21 · FY2007 · CA
Delivering miR-29a to enhance anti-viral and anti-tumor responses in vivo
$191,875Erietta Stelekati · University Of Miami School Of Medicine · R21 · FY2024 · AI
Neuronal control of body weight and size by the Gbeta5-R7 signaling complex
$191,875Vladlen Z Slepak · University Of Miami School Of Medicine · R56 · FY2019 · DK
Identification of resistance mechanisms to direct KRAS inhibition in pancreatic cancer
$191,864Andrew M Waters · University Of Cincinnati · K22 · FY2024 · CA
Identification of resistance mechanisms to direct KRAS inhibition in pancreatic cancer
$191,864Andrew M Waters · University Of Cincinnati · K22 · FY2023 · CA
Identification of resistance mechanisms to direct KRAS inhibition in pancreatic cancer
$191,864Andrew M Waters · University Of Cincinnati · K22 · FY2025 · CA
Exploring the Role of Mitochondrial Fission in Pancreatic Tumorigenesis
$191,853David Francis Kashatus · University Of Virginia · R01 · FY2017 · CA
Glycan control of stem cell-associated pathways in pancreatic cancer
$191,835Susan L Bellis · University Of Alabama At Birmingham · R21 · FY2015 · CA
Developing Therapy for the Treatment of Cholangiocarcinoma
$191,835Karina J Yoon · University Of Alabama At Birmingham · R21 · FY2016 · CA
Project 3: Combination inhibition of ERK for pancreatic cancer treatment
$191,826Andrea Wang-Gillam · Washington University · P50 · FY2019 · CA
Multi-Modal Gene Therapy for Pancreatic Cancer using Targeted Nanovectors
$191,785Mansoor M. Amiji · Northeastern University · U54 · FY2012 · CA
CXCL12/CXCR4 Signaling - A Novel Target for Pancreatic Intraepithelial Neoplasia
$191,700Joseph Kim · Beckman Research Institute/City Of Hope · K22 · FY2011 · CA
Etiology and Tumor Characteristics of Early-onset Pancreatic Cancer
$191,700Chen Yuan · Cedars-Sinai Medical Center · K22 · FY2025 · CA
CXCL12/CXCR4 Signaling - A Novel Target for Pancreatic Intraepithelial Neoplasia
$191,700Joseph Kim · Beckman Research Institute/City Of Hope · K22 · FY2009 · CA
CXCL12/CXCR4 Signaling - A Novel Target for Pancreatic Intraepithelial Neoplasia
$191,700Joseph Kim · Beckman Research Institute/City Of Hope · K22 · FY2010 · CA
AKT Function in Pancreatic Tumor Cell Invasiveness and In Vivo Pathogenesis.
$191,676Deborah A Altomare · Fox Chase Cancer Center · R21 · FY2009 · CA
Understanding the origins of rapid recurrence of pancreatic cancer after resection
$191,618Brian J Druker · Oregon Health & Science University · P30 · FY2022 · CA
The role of EGFR signaling in progression of Kras-induced pacreatic tumors
$191,523Anna L Means · Vanderbilt University · R21 · FY2007 · CA